Answer
No. It is an immune-checkpoint inhibitor that helps immune cells attack cancer rather than directly damaging rapidly dividing cells like conventional chemotherapy.
Sources for this answer
- Bavencio 20 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- NHSNHS · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.